ADMA Biologics, Inc.ADMANASDAQ
Loading
Year-over-year earnings per share growth rate
3Y CAGR
+0.3%/yr
vs +16.7%/yr prior
Acceleration
-16.5pp
Decelerating
Percentile
P82
Within normal range
vs 3Y Ago
1x
Modest growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 40.00% |
| Q3 2025 | 7.14% |
| Q2 2025 | 27.27% |
| Q1 2025 | -76.60% |
| Q4 2024 | 213.33% |
| Q3 2024 | 7.14% |
| Q2 2024 | 79.95% |
| Q1 2024 | 199.62% |
| Q4 2023 | -785.09% |
| Q3 2023 | 139.86% |
| Q2 2023 | 50.26% |
| Q1 2023 | 4.64% |
| Q4 2022 | 39.70% |
| Q3 2022 | -42.65% |
| Q2 2022 | 61.06% |
| Q1 2022 | -95.44% |
| Q4 2021 | 29.15% |
| Q3 2021 | 13.33% |
| Q2 2021 | 6.25% |
| Q1 2021 | 20.00% |
| Q4 2020 | -5.26% |
| Q3 2020 | 17.39% |
| Q2 2020 | 11.54% |
| Q1 2020 | -44.44% |
| Q4 2019 | 5.26% |
| Q3 2019 | 24.00% |
| Q2 2019 | 10.71% |
| Q1 2019 | 28.21% |
| Q4 2018 | -18.18% |
| Q3 2018 | 5.71% |
| Q2 2018 | 10.26% |
| Q1 2018 | -34.48% |
| Q4 2017 | 50.85% |
| Q3 2017 | -7.27% |
| Q2 2017 | -7.84% |
| Q1 2017 | -45.71% |
| Q4 2016 | -2.94% |
| Q3 2016 | 32.00% |
| Q2 2016 | -16.28% |
| Q1 2016 | 2.27% |